Affiliation:
1. Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia , USA
2. Cherokee Nation Assurance , Arlington, Virginia , USA
3. Center for Health Research, Kaiser Permanente Northwest , Portland, Oregon , USA
Abstract
Abstract
Background
While enteric viruses are highly transmissible, household factors associated with transmission are less well documented. We identified individual- and household-level factors associated with viral acute gastroenteritis (AGE) transmission in a large health care network in the United States.
Methods
Patients presenting with AGE were enrolled from April 2014 to September 2016. Patients and symptomatic household members were interviewed, and stool specimens were collected and tested for viral pathogens. Within a household, primary cases were those with the earliest symptom onset and a positive viral test result; secondary cases were household contacts (HHCs) with symptom onset 1-7 days from the primary case onset. Transmission households had at least 1 secondary case.
Results
Our analysis included 570 primary cases with 1479 HHCs. The overall secondary attack rate was 23%. HHCs were likely to become secondary cases (n = 338) if they were <5 years old (adjusted odds ratio [aOR], 1.8; 95% CI, 1.2–2.6). Secondary transmission was likely to occur if the primary case was aged <5 years (aOR, 2.2; 95% CI, 1.4–3.6) or 5 to 17 years (aOR, 3.3; 95% CI, 1.9–5.7), was norovirus positive (aOR, 2.7; 95% CI, 1.9–3.7), had a diapered contact (aOR: 2.2, 95% CI: 1.6-3.2), or reported symptoms for >4 days (aOR, 1.5; 95% CI, 1.1–2.1). Households with ≥3 members (aOR, 2.1; 95% CI, 1.1–4.5) were more likely to experience transmission.
Discussion
Risk of AGE transmission within households increased if the primary case was younger, was norovirus positive, had a longer symptom duration, or had a diapered contact. Targeted prevention messaging around appropriate cleaning, disinfection, and isolation of persons with AGE should be encouraged.
Funder
Kaiser Permanente Center for Health Research
Takeda Vaccines, Inc
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Oncology